Itraconazole

• CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting
  2024-517004-11-00 Phase III 1 country Centre Hospitalier Universitaire De Poitiers
• A Clinical Trial to learn about the effects of TLN-372 when given Alone and in Combination with Other Anti-Tumor Agents in people with Advan… Recruiting
  2025-523086-22-00 Phase I (FiH) 1 country Treeline Biosciences Inc.
• Itraconazole (ITRA) with standard radiotherapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma multiforme (GBM) IT… Recruiting
  2024-519239-40-01 Phase I (Other) 1 country Otto Von Guericke Universitaet Magdeburg
• A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EF… Ended
  2025-521508-23-00 Phase I (Other) 1 country Minoryx Therapeutics S.L.
• A study in healthy men to test whether itraconazole influences the amount of BI 1584862 in the blood Ended
  2023-503542-31-00 Phase I/II 1 country Boehringer Ingelheim International GmbH
• A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus f… Ended
  2023-504727-32-00 Phase II 2 countries Palau Pharma S.L.
• A study in healthy men to test how itraconazole influences the amount of BI 1815368 in the blood Ended
  2023-503783-16-00 Phase I (Other) 1 country Boehringer Ingelheim International GmbH

Showing 1–7 of 7 trials